Elevance Health(ELV) - 2024 Q3 - Quarterly Results

E A R N I N G S R E L E A S E ELEVANCE HEALTH REPORTS THIRD QUARTER 2024 RESULTS • 3Q 2024 operating revenue of $44.7 billion 1 • 3Q 2024 adjusted operating gain of$2.4 billion 2 1 • 3Q 2024 diluted EPS of $4.36; adjusted diluted EPS of$8.37 • 4Q 2024 dividend of $1.63 per share declared to shareholders Indianapolis, IN - October 17, 2024 - Elevance Health, Inc. (NYSE: ELV) reported third quarter 2024 results. "We remain confident in the long-term earnings potential of our diverse businesses as we navigat ...